Release Details

Webcast scheduled for Wednesday, August 9 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., July 26, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, August 9^th at 11:30 a.m. Eastern Time to discuss its second quarter 2023 financial results.

The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A  replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-second-quarter-2023-financial-results-webcast-301885526.html

SOURCE Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals Investor Contact: D. Wade Walke, Ph.D. - info@ionisph.com - 760-603-2331; Ionis Pharmaceuticals Media Contact: David Polk, J.D. - ionis_ca@ionisph.com - 760-603-4679